Korea's SBS asks whether Wegovy should be covered by national health insurance as reports of vision loss side effects put the drug under scrutiny.
Recap by typeshit. Full story at SBS 뉴스.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
Online sellers pitch peptides for weight loss, anti-aging and muscle gain, and Gavin Coote's full story looks at the risks of products nobody regulates.
McIntyre says he gets asked about this worldwide and shares a summary of the mechanistic data on GLP-1 drugs and loss of pleasure.
Young users describe buying retatrutide, GHK-Cu and BPC-157 online, while doctors say the evidence behind many claims is weak.
Loading…